Drug Facts | Docusate Sodium

07:52 EDT 30th September 2014 | BioPortfolio
Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

Each softgel contains: Docusate Sodium, 50% w/w in polyethylene glycol 400 (provides 100 mg Docusate Sodium)

Temporary relief of occasional constipation. This product generally produces a bowel movement in 12 to 72 hours.

If abdominal pain, nausea or vomiting are present.

You have noticed a sudden change in bowel habits that persist over a period of 2 weeks. You are presently taking mineral oil. Stop use and ask a doctor if: Rectal bleeding or failure to have a bowel movement occur after use, which may indicate a serious condition. You need to use a laxative for more than 1 week.

Ask a health professional before use.

KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN.

In case of overdose, get medical help or contact a Poison Control Center immediately.

Adults and children 12 years of age and over. Take 1 to 3 softgels daily.

Children 2 to under 12 years. Take 1 softgel daily.

Children under 2 years ask a doctor.

Each softgel contains: Sodium, 5mg

Store at 15°-30°C (59°-86°F). Protect from excessive moisture.

Gelatin, Polyethylene Glycol 400, Sorbitol Special™ (Sorbitol, sorbitol anhydrides, purified water and mannitol), Glycerin, Purified Water, Propylene Glycol, FD&C Red #40, FD&C Yellow #6, Edible white printing ink.

ADDITIONAL LABEL TEXT

NDC 63739-089-01

DOCUSATE SODIUM 100 mg Sofgels™

STOOL SOFTENER

UD 750 Softgels (25X30)

Mfg. By: Banner Pharmacaps® High Point, NC USA 27265

Dist. By: McKesson Packaging Concord, NC 28027

FOR INSTITUTIONAL USE ONLY.See window at back of box for expiration date and lot number.

LS-089-01-M07-01-A-R1

ADDITIONAL LABEL TEXT

NDC 63739-089-03

DOCUSATE SODIUM 100 mg Sofgels™

STOOL SOFTENER

PC 750 Softgels (25X30)

Mfg. By: Banner Pharmacaps® High Point, NC USA 27265

Dist. By: McKesson Packaging Concord, NC 28027

FOR INSTITUTIONAL USE ONLY.See window at back of box for expiration date and lot number.

ADDITIONAL LABEL TEXT

NDC 63739-089-10

DOCUSATE SODIUM100 mg Sofgels™

STOOL SOFTENER

UD 100 Softgels (10x10)

For Directions and Other Warnings: See accompanying Patient Insert.Consult a physician before the use of this product.

Mfg. By: Banner Pharmacaps® High Point, NC USA 27265

Manufacturer

McKesson Packaging Services Business Unit of McKesson Corporation

Active Ingredients

Source

Drugs and Medications [115 Associated Drugs and Medications listed on BioPortfolio]

Surfak stool softener [Chattem, Inc.]

Surfak Stool Softener

Docusate sodium [SPIRIT PHARMACEUTICALS,LLC]

DOCUSATE SODIUM CAPSULES USP 50 MG

Docusate sodium [SPIRIT PHARMACEUTICALS,LLC]

Docusate Sodium capsules USP 100mg

Promolaxin [Physicians Science & Nature Inc.]

Promolaxin™ Docusate Sodium Stool Softener

Docusate sodium [Contract Pharmacy Services-PA]

Docusate Sodium 100 mg

Clinical Trials [870 Associated Clinical Trials listed on BioPortfolio]

Effectiveness of Docusate in Preventing/Treating Constipation in Palliative Care Patients

The purpose of this study is to determine if docusate is effective in the treatment of constipation in palliative care patients.

Bowel Function After Minimally Invasive Urogynecologic Surgery

The purpose of this study is to assess the effect of a standardized postoperative bowel regimen of over-the-counter medications in subjects undergoing minimally invasive urogynecologic sur...

The Effect of Hypertrophic Pyloric Stenosis (HPS) on Sodium Intake in Childhood

The loss of sodium during infancy causes long term changes in sodium intake. Human research shows that the loss of maternal sodium during pregnancy and neonatal after birth causes an incre...

Phase II Study of Sodium Phenylbutyrate, Sodium Benzoate, Sodium Phenylacetate, and Dietary Intervention for Urea Cycle Disorders

OBJECTIVES: I. Assess the safety and efficacy of sodium phenylbutyrate, sodium benzoate, sodium phenylacetate, and dietary intervention in patients with urea cycle disorders.

A Six Month Clinical Study Based in the US to Evaluate the Efficacy and Tolerability of Sodium Bicarbonate Toothpaste and Its Effect on Opportunistic or Resistant Organisms

This study will compare the Gingival Bleeding and Gingival Inflammation following twice daily use of a sodium bicarbonate experimental dentifrice compared to a 0% sodium bicarbonate toothp...

PubMed Articles [1690 Associated PubMed Articles listed on BioPortfolio]

Efficacy and side-effect profiles of lactulose, docusate sodium, and sennosides compared to PEG in opioid-induced constipation: a systematic review.

Opioid-induced constipation (OIC) is a side effect of opioid therapy that can affect quality of life, adherence to treatment, and morbidity and possibly mortality.

A comprehensive analysis of sodium levels in the canadian packaged food supply.

Population-wide sodium reduction strategies aim to reduce the cardiovascular burden of excess dietary sodium. Lowering sodium in packaged foods, which contribute the most dietary sodium, is an importa...

High sodium intake in women with metabolic syndrome.

Metabolic syndrome and high sodium intake are associated with frequent cardiovascular events. Few studies have estimated sodium intake in subjects with metabolic syndrome by 24-hour urine sodium excre...

Sodium Homeostasis During Liver Transplantation and Correlation with Outcomes.

Reports of perioperative serum sodium increase in liver transplant (LT) recipients are mostly restricted to unintentional rapid serum sodium overcorrection with subsequent development of central ponti...

Stakeholder Discussion to Reduce Population-Wide Sodium Intake and Decrease Sodium in the Food Supply: A Conference Report From the American Heart Association Sodium Conference 2013 Planning Group.

A 2-day interactive forum was convened to discuss the current status and future implications of reducing sodium in the food supply and to identify opportunities for stakeholder collaboration.

Search BioPortfolio:
Loading
Advertisement

Relevant Topic

Pain
Latest News Clinical Trials Research Drugs Reports Corporate
Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage”. Some illnesses can be excruci...

Advertisement

Drugs and Medication Quicklinks


Searches Linking to this Drug Record